These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
32 related articles for article (PubMed ID: 6803223)
1. Using permeation guidelines to design new antibiotics-A PASsagE into Pseudomonas aeruginosa. Cain BN; Hergenrother PJ Clin Transl Med; 2024 Mar; 14(3):e1600. PubMed ID: 38426413 [No Abstract] [Full Text] [Related]
2. Serological and pyocin typing and antibiotic sensitivity of Pseudomonas aeruginosa strains. Del Piano M; La Palombara P; Picci A; Nicosia R Microbiologica; 1986 Apr; 9(2):253-8. PubMed ID: 3086671 [TBL] [Abstract][Full Text] [Related]
3. [Bacterial etiologic factors of diarrhea in the feces of infants hospitalized at the Clinic in January 1985]. Meisel-Mikołajczyk F; Torbicka E; Rafałowska K; Czerniak E; Brzozowska-Binda A Przegl Epidemiol; 1988; 42(2 |||||||||||||):154-63. PubMed ID: 3148159 [No Abstract] [Full Text] [Related]
4. Pyocin types of clinical strains of Pseudomonas aeruginosa isolated in Morelia, México (1980-1984). Cervantes Vega C; Chávez J; Padilla ME; Rivera AN; Vaca S Rev Latinoam Microbiol; 1986; 28(4):287-91. PubMed ID: 3108986 [No Abstract] [Full Text] [Related]
5. [Typing of Pseudomonas aeruginosa from the feces of healthy and sick children. Methodological comparison between pyocin-typing, lyso-typing and serotyping]. Breunung M Padiatr Grenzgeb; 1981; 20(1-2):113-8. PubMed ID: 6789285 [No Abstract] [Full Text] [Related]
6. A predicted immunity protein confers resistance to pyocin S5 in a sensitive strain of Pseudomonas aeruginosa. Rasouliha BH; Ling H; Ho CL; Chang MW Chembiochem; 2013 Dec; 14(18):2444-6. PubMed ID: 24222552 [No Abstract] [Full Text] [Related]
7. [Drug sensitivity and pyocin typing of Pseudomonas aeruginesa strains from feces of infants with diarrhea]. Swiderski M; Skrzypczak A Pediatr Pol; 1981; 56(11-12):1339-43. PubMed ID: 6803223 [No Abstract] [Full Text] [Related]
8. [Pseudomonas aeruginosa. Application of serotyping and pyocin typing to strains isolated in Algeria]. Kezzal K; Rahal K Arch Inst Pasteur Alger; 1986; 55():61-77. PubMed ID: 3152815 [No Abstract] [Full Text] [Related]
9. Current therapies for pseudomonas aeruginosa. Giamarellou H; Kanellakopoulou K Crit Care Clin; 2008 Apr; 24(2):261-78, viii. PubMed ID: 18361945 [TBL] [Abstract][Full Text] [Related]
10. Questioning the paradigm: monotherapy vs combination antimicrobial therapy for treatment of Pseudomonas aeruginosa. DeRyke CA; Kuti JL; Nicolau DP Conn Med; 2005 May; 69(5):271-5. PubMed ID: 16114642 [No Abstract] [Full Text] [Related]
11. [Active drugs against Pseudomonas aeruginosa and their clinical usefulness]. Gobernado M Rev Clin Esp; 1998 Sep; 198 Suppl 2():51-61. PubMed ID: 9844479 [No Abstract] [Full Text] [Related]
12. [Chemotherapy of infections caused by Pseudomonas aeruginosa (pyocyanosis)]. Chernomordik AB; Panchenko MK; Bulycheva NP Klin Med (Mosk); 1982 Jun; 60(6):17-20. PubMed ID: 6811797 [No Abstract] [Full Text] [Related]